First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel

Lung cancer is the leading cause of cancer mortality worldwide in both men and women. Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of cases. Paclitaxel has a broad spectrum of activity against various malignancies, including NSCLC. Paclitaxe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gupta, Neha, Hatoum, Hassan, Dy, Grace K
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875520/
https://ncbi.nlm.nih.gov/pubmed/24399877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S41770
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki